Table 4 Radiotherapy related acute adverse events
From: Optimized radiotherapy to improve clinical outcomes for locally advanced lung cancer
SMART (n = 59) | H-RT (n = 14) | P value | Total (n = 73) | |
|---|---|---|---|---|
Pneumonitis | ||||
Grade 2 | 5 (8%) | 0 (0%) | NS | 5 (7%) |
Grade 3 | 3 (5%) | 1 (7%) | NS | 4 (5%) |
Grade 4 | 1 (2%) | 0 (0%) | NS | 1 (1%) |
Oesophagitis | ||||
Grade 1 | 29 (49%) | 10 (71%) | NS | 39 (53%) |
Grade 2 | 23 (39%) | 2 (14%) | NS | 25 (34%) |
Grade 3 | 1 (2%) | 0 (0%) | NS | 1 (1%) |